CAS-One IR
Cascination AG · Decision date Sep 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for CAS-One IR, submitted by Cascination AG of Bern, Switzerland, under 510(k) number K261225. The public database lists the decision date as September 29, 2026, with the application received April 15, 2026, while the clearance letter in the summary document is dated August 28, 2026; the record does not reconcile those dates. The device is classified as a computed tomography x-ray system under 21 CFR 892.1750, Class II, product code JAK, in the radiology specialty. SESE denotes 510(k) clearance, not premarket approval.
The subject device comprises CAS-One IR Software as the parent device plus eight accessories, including a platform, baseplate, cushion, accessory tray, aiming device, guide arm, pointer and consumable set. The summary describes it as an updated version of predicate K232022, with intended use, functionality, use context and workflow stated as unchanged. The summary states the accessories perform no standalone medical function independent of the software. The record does not include performance testing data or a detailed comparison of changes from the predicate.
The indications describe a user-controlled stereotactic accessory for planning, navigation and verification during CT-guided percutaneous procedures with rigid straight instruments, for patients older than 18 years. Those indications are attributed to the September 2026 summary and should not be read as current labeling beyond this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Sep 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261225
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Cascination AG
- Product code
- JAK
- Decision code
- SESE
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, X-Ray, Tomography, Computed.
- Applicant
- Cascination AG
- Product code
- JAK
- FDA device class
- 2
FDA decision timeline
K261225 received
Application receipt date recorded by FDA.
K261225 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JAK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AVIEW Aorta MetricsK260391 | Coreline Soft Co., Ltd. | 510(k) clearance | Oct 16, 2026 | FDA |
| Samsung HME America, Inc., dba NeuroLogica Corp. | 510(k) clearance | Sep 22, 2026 | FDA | |
SCENARIA View Phase 6.0K261229 | Fujifilm Corporation | 510(k) clearance | Sep 18, 2026 | FDA |
FCT iStream Phase 2K253836 | Fujifilm Corporation | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cascination AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Bern
Sources and methodology
- Original FDA record: K261225
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

